Athersys
Cleveland
About Athersys
Athersys is a biopharmaceutical company that discovers and develops therapeutic products to treat several disease indications. The company's product development portfolio includes MultiStem, a stem cell product, that is being developed as a treatment for multiple disease indications, is being evaluated in two ongoing clinical trials, and has been authorized for use in a third clinical trial. In addition, Athersys develops pharmaceuticals to treat indications such as obesity, certain cognitive and attention disorders, narcolepsy, or other forms of excessive daytime sleepiness.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $208.9M
- Funding stage: IPO
- Last round: Post-IPO Equity (Apr 2023)
- Ticker: nasdaq:ATHX
- Website: athersys.com
- Phone: (216)431-9900
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/athersys-2242083 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.